Brief: T2 Biosystems Regains Compliance With Nasdaq’S Market Value Of Listed Securities Requirement
09/08/2023 15:00
Aug 9 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS REGAINS COMPLIANCE WITH NASDAQ’S MARKET
VALUE OF
LISTED SECURITIES REQUIREMENT
Source text for Eikon: ID:nGNXcc0Dyt
Further company coverage: TTOO.O
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor